|
- Health products policy and standards
This web page links to all current WHO norms and standards for pharmaceuticals guidelines which are grouped into (1) development, (2) production, (3) distribution, (4) inspection, (5) quality control, (6) regulatory standards and (7) specific texts for prequalification of medicines
- World Health Organization (WHO)
The United Nations agency working to promote health, keep the world safe and serve the vulnerable
- WHO GUIDELINES ON - World Health Organization
The WHO Guidelines on physical activity and sedentary behaviour provide evidence-based public health recommendations for children, adolescents, adults and older adults on the amount of physical activity (frequency, intensity and duration) required to ofer significant health benefits and mitigate health risks
- Technical guidance - World Health Organization (WHO)
Collection of WHO technical guidance on COVID-19, updated based on new scientific findings as the epidemic evolves
- WHO guideline on self-care interventions for health and well-being . . .
This chapter provides key background information about self-care and self-care interventions and an overview of the guideline, including brief summaries of how it was developed, the way it should be used and the scope of the guideline
- Handbook - WHO
The Guidelines Review Committee (GRC) was established by the Director-General in 2007 to ensure that WHO guidelines are of high quality and are developed through a transparent, evidence-based decision-making process
- WHO guidelines for the treatment of patients with cystic echinococcosis . . .
As part of developing the guidelines for the treatment of patients with cystic echinococcosis, evidence-to-decision (EtD) frameworks were used to produce the recommendations for each PICO question
- Guidelines for Development of WHO Guidelines:
Work from developing countries show that several factors increase the impact of practice guidelines: involvement of the end-users in guidelines development, launch and introduction of the guidelines, multiple training modalities, feedback to prescribers on their prescription practices in relation to guidelines and effective monitoring and
|
|
|